We are live on ! Find out more
DCM

DME Capital Management Portfolio holdings

AUM $3.19B
1-Year Est. Return 23.22%
This Fund
S&P 500
This Quarter Est. Return
+7.64%
1 Year Est. Return
+23.22%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.18B
AUM Growth
–
Cap. Flow
+$2.06B
Cap. Flow %
94.24%
Top 10 Hldgs %
72.95%
Holding
42
New
42
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
GRBK icon
Green Brick Partners
GRBK
+$561M
2
BHF icon
Brighthouse Financial
BHF
+$150M
3
CNR
Core Natural Resources Inc
CNR
+$146M
4
KD icon
Kyndryl
KD
+$140M
5
ALIT icon
Alight
ALIT
+$104M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 39.21%
2 Technology 14.39%
3 Healthcare 13.54%
4 Energy 11.4%
5 Financials 9.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
COYA icon
26
Coya Therapeutics
COYA
$113M
$12.6M 0.58%
+1,274,026
New +$9.98M
GPRO icon
27
GoPro
GPRO
$114M
$6.3M 0.29%
+2,823,100
New +$7.54M
LKFT
28
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.88B
$5.15M 0.24%
+159,828
New +$5.94M
TEVA icon
29
Teva Pharmaceuticals
TEVA
$42.5B
$4.58M 0.21%
+324,850
New +$4.09M
OIH icon
30
VanEck Oil Services ETF
OIH
$1.97B
$3.77M 0.17%
+11,220
New +$3.4M
SHC icon
31
Sotera Health
SHC
$5.45B
$3.6M 0.17%
+300,110
New +$4.47M
GDX icon
32
VanEck Gold Miners ETF
GDX
$27.5B
$3.52M 0.16%
+111,390
New +$3.16M
DNMR
33
DELISTED
Danimer Scientific, Inc.
DNMR
$2.98M 0.14%
+68,365
New +$2.83M
GANX icon
34
Gain Therapeutics
GANX
$87.9M
$2.13M 0.1%
+566,130
New +$2.35M
CLVT icon
35
Clarivate
CLVT
$1.22B
$2.08M 0.1%
+279,560
New +$2.33M
FCG icon
36
First Trust Natural Gas ETF
FCG
$651M
$1.94M 0.09%
+70,830
New +$1.73M
PDBC icon
37
Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF
PDBC
$6.66B
$1.63M 0.07%
+117,360
New +$1.58M
TLIS
38
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
$1.3M 0.06%
+149,052
New +$1.23M
NUVB icon
39
Nuvation Bio
NUVB
$2.24B
$127K 0.01%
+34,995
New +$67.2K
NBSE
40
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$61.3K ﹤0.01%
+136,350
New +$103K
NUVB.WS
41
DELISTED
Nuvation Bio Inc Warrants
NUVB.WS
$30.3K ﹤0.01%
+100,000
New +$11.9K
KPLTW
42
DELISTED
Katapult Holdings Warrant
KPLTW
$5.19K ﹤0.01%
+262,227
New +$3.72K
1
2

Similar funds

FAM
Foxhaven Asset Management Charlottesville, Virginia $3.19B AUM 12.34% 1-Year Est. Return
BIG
Brooklyn Investment Group Brooklyn, New York $3.2B AUM 26.32% 1-Year Est. Return
HCM
Himalaya Capital Management Seattle, Washington $3.2B AUM 32.2% 1-Year Est. Return
SC
SummitTX Capital Fort Worth, Texas $3.2B AUM 41.22% 1-Year Est. Return
YCM
Yaupon Capital Management New York $3.2B AUM 46.52% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
SYBT
Stock Yards Bank & Trust Louisville, Kentucky $3.21B AUM 22.76% 1-Year Est. Return
EWA
Exencial Wealth Advisors Oklahoma City, Oklahoma $3.22B AUM 20.17% 1-Year Est. Return

DME Capital Management's Q1 2024 Portfolio in Review

Q1 2024 is the first quarter with a 13F filing on record for DME Capital Management, which disclosed 42 positions worth $2.18B. Its ten largest holdings account for 73% of the portfolio.

Its largest position is Green Brick Partners: 10,467,383 shares worth $630M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 39% of assets, followed by Technology and Healthcare.

  • DME Capital Management's largest Q1 2024 buy was Green Brick Partners: 10,467,383 shares worth $630M.
  • DME Capital Management's ten largest holdings make up 73% of its $2.18B portfolio in Q1 2024.
  • DME Capital Management disclosed 42 positions in Q1 2024, its first 13F filing on record.

Based on DME Capital Management's 13F filing for Q1 2024, filed 15 May 2024.